Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis

Overview of attention for article published in Drug Development & Industrial Pharmacy, May 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,083 followers.

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis. https://t.co/M8BziHzCvP

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resista... https://t.co/FEZHkYS8Dc

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.